Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies ; volume:24 ; number:1 ; day:10 ; month:2 ; year:2024 ; pages:1-18 ; date:12.2024
Cancer cell international ; 24, Heft 1 (10.2.2024), 1-18, 12.2024
- Urheber
-
Abdolvahab, Mohadeseh Haji
Karimi, Pegah
Mohajeri, Nasrin
Abedini, Mohammad
Zare, Hamed
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-024-03259-8
- URN
-
urn:nbn:de:101:1-2404190753530.859685533659
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abdolvahab, Mohadeseh Haji
- Karimi, Pegah
- Mohajeri, Nasrin
- Abedini, Mohammad
- Zare, Hamed
- SpringerLink (Online service)
Ähnliche Objekte (12)
GFP nanobodies reveal recently-exocytosed pHluorin molecules
Nanobodies: new avenue to treat kidney disease
The Therapeutic Potential of Nanobodies
Nanobodies – effektive Immunwaffen gegen Krebs
ASC nanobodies to counteract the consequences of inflammasome activation
Antithrombin inhibition using nanobodies to correct bleeding in hemophilia
Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
A few good reasons to use nanobodies for cancer treatment
Allosteric nanobodies to study the interactions between SOS1 and RAS
Interaction standards for biophysics: anti-lysozyme nanobodies
Regulating voltage-gated ion channels with nanobodies
Therapeutische Nanobodies gegen SARS-CoV-2
GFP nanobodies reveal recently-exocytosed pHluorin molecules
Nanobodies: new avenue to treat kidney disease
The Therapeutic Potential of Nanobodies
Nanobodies – effektive Immunwaffen gegen Krebs
ASC nanobodies to counteract the consequences of inflammasome activation
Antithrombin inhibition using nanobodies to correct bleeding in hemophilia
Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
A few good reasons to use nanobodies for cancer treatment
Allosteric nanobodies to study the interactions between SOS1 and RAS
Interaction standards for biophysics: anti-lysozyme nanobodies
Regulating voltage-gated ion channels with nanobodies
Therapeutische Nanobodies gegen SARS-CoV-2
GFP nanobodies reveal recently-exocytosed pHluorin molecules
Nanobodies: new avenue to treat kidney disease
The Therapeutic Potential of Nanobodies
Nanobodies – effektive Immunwaffen gegen Krebs
ASC nanobodies to counteract the consequences of inflammasome activation
Antithrombin inhibition using nanobodies to correct bleeding in hemophilia
Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
A few good reasons to use nanobodies for cancer treatment
Allosteric nanobodies to study the interactions between SOS1 and RAS
Interaction standards for biophysics: anti-lysozyme nanobodies
Regulating voltage-gated ion channels with nanobodies